U.S. Markets close in 43 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,258.23 | 31.29 | 0.31% |
| NASDAQ | 2,155.29 | 1.23 | 0.06% |
| S&P 500 | 1,094.61 | 1.53 | 0.14% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 28.30 09:32 AM EST | |
|---|---|---|
| Day High | 28.99 01:44 PM EST |
|
| Range | 0.69 |
| Volume | 245,511 | |
|---|---|---|
| 30-Day Avg Vol | 432,000 |
|
| Difference | -43.17% |
| Market Cap | 968.42 M | |
|---|---|---|
| Mkt Cap Chg | 18.09 M |
| Shares Out | 33.50 M | |
|---|---|---|
| % Shrs Traded | 0.73% | |
| 1yr EPS Est | -2.546 |
| 52-Wk Low | 11.27 | |
|---|---|---|
| 52-Wk High | 28.99 1:44 PM EST |
|
| Range | 17.72 |
| Prev Close | 28.36 11/9/09 | |
|---|---|---|
| Today's Open | 28.31 | |
| Change | -0.18% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 3.61 M |
| Revenue (LFY) | 12.57 M | |
|---|---|---|
| Earnings (LFY) | -62.46 M | |
| Earnings (MRQ) | -13.97 M | |
| Next Earn Est | -0.603 | |
| Next Earnings | 03/15/2010 |
|
| EPS (TTM) | -1.16 | |
| 1yr EPS Growth | -119.48% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -11.00 | |
| PEG Ratio | — | |
| Return on Equity | -275.85 | |
| Beta | 1.55 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Medivation motivates medicine makers. The company acquires, develops, and sells (or partners with companies working on) early-development stage biopharmaceuticals. Medivation initiates drug development ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.603 3/15/10 | — — |
—
—
|
| Last Quarter | -0.393 9/30/09 | -0.42 9/30/09 |
-0.027
Missed
|
| 2 Quarters Ago | -0.318 6/30/09 | -0.29 6/30/09 |
0.028
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 16.34 M | 12.58 M |
| Gross Profit | 16.26 M | 12.38 M |
| Operating Income | -11.22 M | -64.18 M |
| Net Income | -13.97 M | -62.46 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts